153389 - Pharmacogenomics Explained: A New Approach to Personalised Medicine
- : Online
This activity is to provide an update to Australian general practitioners (GP's) and their practice team on the current development of pharmacogenomics and its clinical application in general practice.
This will support and improve the way GP's prescribe a substantial number of medications for their patients. This education module aims to provide a brief background on the science that underpins pharmacogenomics coupled with clinical case studies to illustrate the clinical application of this type of testing in general practice.
In 2008, Deloitte Economics concluded that Australia could achieve more than $12 billion in economic benefit by the wide spread adoption of pharmacogenomics. This is partly achieved by avoidance of adverse drug reactions and unnecessary pharmaceutical spending. A number of authorities including The Australian Medicines Handbook, eMIMS, FDA, as well as Clinical Pharmacogenetic Implementation Consortium have made dosage recommendations in their current guidelines for a number of medications based on the metabolising enzyme genotype result, which is a clear application of pharmacogenomics in clinical practice.Learning outcomes